COMMODORE CAPITAL LP filings

Add to watchlist

This page lists the SEC filings reported by COMMODORE CAPITAL LP.

All
Holdings
Significant ownership
Insider transactions
Events
Shareholder votes
SEC filings by COMMODORE CAPITAL LP (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2024-04-19COMMODORE CAPITAL LPPerspective Therapeutics, Inc.38,906,6736.6%EDGAR
SC 13G2024-03-21COMMODORE CAPITAL LPMind Medicine (MindMed) Inc.5,833,3338.3%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPVera Therapeutics, Inc.5,001,78311.3%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPAdverum Biotechnologies, Inc.10,000,0009.9%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPAmbrx Biopharma, Inc.00.0%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPCabaletta Bio, Inc.1,900,0004.4%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPCelcuity Inc.2,492,8869.9%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPCogent Biosciences, Inc.6,172,0867.1%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPCymaBay Therapeutics, Inc.00.0%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPEnliven Therapeutics, Inc.2,901,8167.0%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPIMMUNIC, INC.00.0%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPMerus N.V.4,747,3738.2%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPSAB Biotherapeutics, Inc.1,831,7463.5%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPSOLENO THERAPEUTICS INC700,0002.3%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPSpyre Therapeutics, Inc.1,934,0845.4%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPViridian Therapeutics, Inc.\DE1,924,0743.7%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPVera Therapeutics, Inc.5,450,00012.3%EDGAR
SC 13G2024-01-19COMMODORE CAPITAL LPAdicet Bio, Inc.4,250,0009.8%EDGAR
SC 13G2023-12-22COMMODORE CAPITAL LPC4 Therapeutics, Inc.3,800,0007.7%EDGAR
SC 13G2023-12-01COMMODORE CAPITAL LPSpyre Therapeutics, Inc.1,834,0846.1%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.